Cargando…
Expanding roles for academic entrepreneurship in drug discovery
An assessment of inventors of US Food and Drug Administration (FDA)-approved medicines reveals a growing role for academic entrepreneurship in general and National Institutes of Health (NIH)-supported investigators in particular. For all small-molecule therapeutics approved between 2001 and 2019 (38...
Autores principales: | Kinch, Michael S., Horn, Caitlin, Kraft, Zachary, Schwartz, Tyler |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7484702/ https://www.ncbi.nlm.nih.gov/pubmed/32920058 http://dx.doi.org/10.1016/j.drudis.2020.09.004 |
Ejemplares similares
-
Rising Academic Contributions to Drug Development:
Evidence of Vigor or Trauma?
por: Kinch, Michael S., et al.
Publicado: (2020) -
Converging global crises are forcing the rapid adoption of disruptive changes in drug discovery
por: Treherne, J. Mark, et al.
Publicado: (2021) -
COVID-19’s Disruptive Innovation: Accelerating the Academic Preparation of Professional Nurses’ Ambulatory and Telehealth Roles
por: Kollman, Sara, et al.
Publicado: (2022) -
Commercialisation and entrepreneurship – an academic viewpoint
Publicado: (2022) -
Expanding during a pandemic with the looming threat of recession
por: Pitchforth, Ashkan
Publicado: (2021)